{"hands_on_practices": [{"introduction": "Resistance to antibiotics is fundamentally a biophysical phenomenon. This exercise will allow you to quantify the energetic penalty that the VanA mechanism imposes on vancomycin binding, using basic thermodynamic principles. By calculating the change in Gibbs free energy, $\\Delta G^{\\circ}$, you will gain a deeper appreciation for why modifying the drug's target from D-alanyl-D-alanine to D-alanyl-D-lactate is such an effective resistance strategy. [@problem_id:4641792]", "problem": "An advanced pharmacodynamic analysis of glycopeptide binding in Vancomycin Resistant Enterococcus (VRE) is required. Consider the binding of vancomycin to the peptidoglycan precursor in Enterococcus faecium (E. faecium). In vancomycin-susceptible strains, the target terminus is D-alanyl-D-alanine, whereas in VanA-type resistant strains, the terminus is remodeled to D-alanyl-D-lactate, which is empirically observed to increase the dissociation constant by approximately $1000$-fold at physiological temperature $T=310\\,\\mathrm{K}$. Let the binding reaction be represented as $L + R \\rightleftharpoons LR$, where $L$ is vancomycin, $R$ is the target terminus, and $LR$ is the bound complex. Starting from the fundamental definitions of the association constant $K_{a}$ and dissociation constant $K_{d}$ for this equilibrium, and the thermodynamic definition of the standard Gibbs free energy change $\\Delta G^{\\circ}$ for an equilibrium process, derive the expression that links the standard binding free energy $\\Delta G^{\\circ}_{\\text{bind}}$ to $K_{d}$. Then, compute the change in standard binding free energy, $\\Delta \\Delta G^{\\circ}_{\\text{bind}}$, when $K_{d}$ increases $1000$-fold at $T=310\\,\\mathrm{K}$. Use the molar gas constant $R = 8.314\\,\\mathrm{J\\,mol^{-1}\\,K^{-1}}$. Express your numerical result in kilojoules per mole ($\\mathrm{kJ\\,mol^{-1}}$) and round your answer to four significant figures. Finally, interpret the pharmacological consequence for activity at a fixed extracellular vancomycin concentration by reasoning from receptor occupancy and thermodynamic favorability, without invoking any empirical minimum inhibitory concentration (MIC) values.", "solution": "The problem is assessed to be valid. It is scientifically grounded in the established biochemical basis of vancomycin resistance, well-posed with sufficient information for a unique solution, and expressed in objective, precise language. I will now proceed with the solution.\n\nThe problem requires a three-part solution: first, a derivation of the relationship between the standard binding free energy ($\\Delta G^{\\circ}_{\\text{bind}}$) and the dissociation constant ($K_d$); second, the calculation of the change in this free energy ($\\Delta \\Delta G^{\\circ}_{\\text{bind}}$) due to resistance; and third, an interpretation of the pharmacological consequences.\n\nPart 1: Derivation of the relationship between $\\Delta G^{\\circ}_{\\text{bind}}$ and $K_d$.\n\nThe binding reaction is given by the equilibrium:\n$$L + R \\rightleftharpoons LR$$\nwhere $L$ represents vancomycin (the ligand), $R$ represents the peptidoglycan precursor terminus (the receptor), and $LR$ is the bound complex.\n\nThe association constant, $K_a$, for this binding equilibrium is defined as the ratio of the concentration of the product to the concentrations of the reactants at equilibrium:\n$$K_a = \\frac{[LR]}{[L][R]}$$\nThe dissociation constant, $K_d$, is the reciprocal of the association constant and corresponds to the equilibrium constant for the reverse reaction, $LR \\rightleftharpoons L + R$:\n$$K_d = \\frac{1}{K_a} = \\frac{[L][R]}{[LR]}$$\nThe standard Gibbs free energy change for a reaction, $\\Delta G^{\\circ}$, is related to its equilibrium constant, $K_{eq}$, by the fundamental thermodynamic equation:\n$$\\Delta G^{\\circ} = -RT \\ln(K_{eq})$$\nwhere $R$ is the molar gas constant and $T$ is the absolute temperature.\n\nThe standard binding free energy, $\\Delta G^{\\circ}_{\\text{bind}}$, corresponds to the association process $L + R \\rightarrow LR$. The equilibrium constant for this process is $K_a$. Therefore, we can write:\n$$\\Delta G^{\\circ}_{\\text{bind}} = -RT \\ln(K_a)$$\nTo relate this to the dissociation constant, $K_d$, we substitute $K_a = 1/K_d$:\n$$\\Delta G^{\\circ}_{\\text{bind}} = -RT \\ln\\left(\\frac{1}{K_d}\\right)$$\nUsing the logarithmic identity $\\ln(1/x) = -\\ln(x)$, the expression becomes:\n$$\\Delta G^{\\circ}_{\\text{bind}} = -RT(-\\ln(K_d)) = RT \\ln(K_d)$$\nThis is the required expression linking the standard binding free energy to the dissociation constant. A more negative $\\Delta G^{\\circ}_{\\text{bind}}$ indicates stronger binding, which corresponds to a smaller $K_d$ value (note that for $K_d < 1$, $\\ln(K_d)$ is negative).\n\nPart 2: Calculation of the change in standard binding free energy, $\\Delta \\Delta G^{\\circ}_{\\text{bind}}$.\n\nLet the parameters for the vancomycin-susceptible (S) and vancomycin-resistant (R) strains be denoted by the subscripts $S$ and $R$, respectively.\nThe standard binding free energy for the susceptible strain is:\n$$\\Delta G^{\\circ}_{S} = RT \\ln(K_{d,S})$$\nThe standard binding free energy for the resistant strain is:\n$$\\Delta G^{\\circ}_{R} = RT \\ln(K_{d,R})$$\nThe change in standard binding free energy, $\\Delta \\Delta G^{\\circ}_{\\text{bind}}$, upon acquiring resistance is the difference between these two values:\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} = \\Delta G^{\\circ}_{R} - \\Delta G^{\\circ}_{S}$$\nSubstituting the expressions for the Gibbs free energies:\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} = RT \\ln(K_{d,R}) - RT \\ln(K_{d,S})$$\nFactoring out the $RT$ term and using the logarithmic identity $\\ln(a) - \\ln(b) = \\ln(a/b)$:\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} = RT \\ln\\left(\\frac{K_{d,R}}{K_{d,S}}\\right)$$\nThe problem states that the dissociation constant increases $1000$-fold in the resistant strain, which means the ratio $\\frac{K_{d,R}}{K_{d,S}} = 1000$.\nSubstituting the given values $R = 8.314$ $\\mathrm{J\\,mol^{-1}\\,K^{-1}}$ and $T = 310$ $\\mathrm{K}$:\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} = (8.314 \\mathrm{~J\\,mol^{-1}\\,K^{-1}}) \\times (310 \\mathrm{~K}) \\times \\ln(1000)$$\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} \\approx (2577.34 \\mathrm{~J\\,mol^{-1}}) \\times (6.907755)$$\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} \\approx 17804.55 \\mathrm{~J\\,mol^{-1}}$$\nTo express the answer in kilojoules per mole ($\\mathrm{kJ\\,mol^{-1}}$), we divide by $1000$:\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} \\approx 17.80455 \\mathrm{~kJ\\,mol^{-1}}$$\nRounding to four significant figures as requested gives:\n$$\\Delta \\Delta G^{\\circ}_{\\text{bind}} = 17.80 \\mathrm{~kJ\\,mol^{-1}}$$\n\nPart 3: Interpretation of the pharmacological consequence.\n\nThe positive value of $\\Delta \\Delta G^{\\circ}_{\\text{bind}} = +17.80 \\mathrm{~kJ\\,mol^{-1}}$ indicates that the binding of vancomycin to the D-alanyl-D-lactate target in the resistant strain is substantially less thermodynamically favorable than its binding to the D-alanyl-D-alanine target in the susceptible strain. This thermodynamic penalty directly translates to a reduced efficacy at the molecular level.\n\nTo formalize this, we consider the fractional receptor occupancy, $\\theta$, which is the fraction of target sites bound by the drug. For a simple $1:1$ binding equilibrium, $\\theta$ is given by the Hill-Langmuir equation:\n$$\\theta = \\frac{[L]}{[L] + K_d}$$\nThis equation demonstrates that for a fixed drug concentration $[L]$, the occupancy $\\theta$ is inversely related to the dissociation constant $K_d$.\n\nIn the resistant strain, $K_d$ is $1000$ times larger than in the susceptible strain ($K_{d,R} = 1000 \\times K_{d,S}$). At any given extracellular vancomycin concentration $[L]$, the target occupancy in the resistant strain ($\\theta_R$) will be drastically lower than in the susceptible strain ($\\theta_S$).\n\nFor example, at a vancomycin concentration equal to the $K_d$ of the susceptible strain, i.e., $[L] = K_{d,S}$:\n- Occupancy in the susceptible strain: $\\theta_S = \\frac{K_{d,S}}{K_{d,S} + K_{d,S}} = \\frac{1}{2} = 0.5$, or $50\\%$ occupancy.\n- Occupancy in the resistant strain: $\\theta_R = \\frac{K_{d,S}}{K_{d,S} + K_{d,R}} = \\frac{K_{d,S}}{K_{d,S} + 1000 K_{d,S}} = \\frac{1}{1001} \\approx 0.001$, or approximately $0.1\\%$ occupancy.\n\nThe pharmacological consequence is a profound failure of the drug to engage its target. Vancomycin's mechanism of action relies on binding to the peptidoglycan precursors to sterically hinder the transglycosylase and transpeptidase enzymes, thereby inhibiting cell wall synthesis. The $1000$-fold increase in $K_d$ means that a $1000$-fold higher concentration of vancomycin would be required to achieve the same level of target occupancy as in the susceptible strain. Such high concentrations are not clinically achievable or safe. Therefore, the remodeling of the target terminus from D-Ala-D-Ala to D-Ala-D-Lac confers resistance by making the drug-target binding event so thermodynamically unfavorable that effective target occupancy cannot be reached at therapeutic drug concentrations. This loss of affinity is the direct molecular cause of resistance.", "answer": "$$\\boxed{17.80}$$", "id": "4641792"}, {"introduction": "In a clinical setting, we often infer the genetic basis of resistance by observing an organism's susceptibility profile, or phenotype. This practice places you in the role of a clinical microbiologist tasked with interpreting Minimum Inhibitory Concentration (MIC) data from a collection of *Enterococcus* isolates. Applying a set of classification rules, you will learn to distinguish between different vancomycin resistance phenotypes like VanA and VanB, a crucial skill for both treatment decisions and epidemiological tracking. [@problem_id:4641811]", "problem": "Surveillance programs in infectious diseases often use Minimum Inhibitory Concentration (MIC) data to infer likely genetic resistance phenotypes of Enterococcus species to glycopeptide antibiotics. The Minimum Inhibitory Concentration (MIC) is defined as the lowest concentration of an antimicrobial agent that prevents visible growth of a microorganism in vitro. Well-tested observations regarding enterococcal glycopeptide resistance phenotypes include the following: the VanA phenotype typically displays high-level resistance to both vancomycin and teicoplanin; the VanB phenotype displays variable resistance to vancomycin but remains susceptible to teicoplanin; and the VanC phenotype displays intrinsic low-level resistance to vancomycin with susceptibility to teicoplanin. In this problem, you will apply a threshold-based classification scheme that operationalizes these observations in a surveillance context.\n\nAssume the following threshold-based classification rules, justified by the observed MIC characteristics of Van operons:\n1. Classify an isolate as VanA if its vancomycin MIC is at least $64\\,\\mathrm{mg/L}$ and its teicoplanin MIC is at least $16\\,\\mathrm{mg/L}$.\n2. Classify an isolate as VanB if its vancomycin MIC is at least $16\\,\\mathrm{mg/L}$ and its teicoplanin MIC is at most $2\\,\\mathrm{mg/L}$.\n3. Classify an isolate as VanC if its vancomycin MIC is at least $4\\,\\mathrm{mg/L}$ but less than $16\\,\\mathrm{mg/L}$ and its teicoplanin MIC is at most $2\\,\\mathrm{mg/L}$.\n4. Classify an isolate as Other if it does not meet any of the above criteria.\n\nYou are given MIC pairs (vancomycin; teicoplanin), both in $\\mathrm{mg/L}$, for a cohort of $20$ Enterococcus isolates:\n- Isolate $1$: vancomycin $128\\,\\mathrm{mg/L}$; teicoplanin $32\\,\\mathrm{mg/L}$.\n- Isolate $2$: vancomycin $256\\,\\mathrm{mg/L}$; teicoplanin $64\\,\\mathrm{mg/L}$.\n- Isolate $3$: vancomycin $64\\,\\mathrm{mg/L}$; teicoplanin $16\\,\\mathrm{mg/L}$.\n- Isolate $4$: vancomycin $16\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $5$: vancomycin $8\\,\\mathrm{mg/L}$; teicoplanin $2\\,\\mathrm{mg/L}$.\n- Isolate $6$: vancomycin $32\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $7$: vancomycin $4\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $8$: vancomycin $12\\,\\mathrm{mg/L}$; teicoplanin $2\\,\\mathrm{mg/L}$.\n- Isolate $9$: vancomycin $6\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $10$: vancomycin $2\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $11$: vancomycin $3\\,\\mathrm{mg/L}$; teicoplanin $2\\,\\mathrm{mg/L}$.\n- Isolate $12$: vancomycin $32\\,\\mathrm{mg/L}$; teicoplanin $4\\,\\mathrm{mg/L}$.\n- Isolate $13$: vancomycin $64\\,\\mathrm{mg/L}$; teicoplanin $2\\,\\mathrm{mg/L}$.\n- Isolate $14$: vancomycin $1\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $15$: vancomycin $10\\,\\mathrm{mg/L}$; teicoplanin $3\\,\\mathrm{mg/L}$.\n- Isolate $16$: vancomycin $128\\,\\mathrm{mg/L}$; teicoplanin $8\\,\\mathrm{mg/L}$.\n- Isolate $17$: vancomycin $512\\,\\mathrm{mg/L}$; teicoplanin $32\\,\\mathrm{mg/L}$.\n- Isolate $18$: vancomycin $8\\,\\mathrm{mg/L}$; teicoplanin $1\\,\\mathrm{mg/L}$.\n- Isolate $19$: vancomycin $16\\,\\mathrm{mg/L}$; teicoplanin $2\\,\\mathrm{mg/L}$.\n- Isolate $20$: vancomycin $5\\,\\mathrm{mg/L}$; teicoplanin $2\\,\\mathrm{mg/L}$.\n\nUsing the rules above, classify each isolate and compute the proportion of isolates that are likely to be VanA in this cohort. Express your final proportion as a unitless decimal rounded to four significant figures.", "solution": "The problem requires the classification of a cohort of $20$ Enterococcus isolates based on their Minimum Inhibitory Concentration (MIC) values for two glycopeptide antibiotics, vancomycin and teicoplanin. Following this classification, the task is to compute the proportion of isolates exhibiting the VanA resistance phenotype.\n\nFirst, we must formalize the provided threshold-based classification rules. Let $V$ represent the MIC of vancomycin in $\\mathrm{mg/L}$, and let $T$ represent the MIC of teicoplanin in $\\mathrm{mg/L}$. The classification for an individual isolate is determined by the following set of conditions:\n1.  **VanA phenotype**: An isolate is classified as VanA if its MICs satisfy the conditions $V \\ge 64$ and $T \\ge 16$.\n2.  **VanB phenotype**: An isolate is classified as VanB if its MICs satisfy the conditions $V \\ge 16$ and $T \\le 2$.\n3.  **VanC phenotype**: An isolate is classified as VanC if its MICs satisfy the conditions $4 \\le V < 16$ and $T \\le 2$.\n4.  **Other**: An isolate is classified as Other if it fails to meet any of the criteria for VanA, VanB, or VanC.\n\nThe problem provides MIC data for $20$ isolates. We will systematically apply the classification rules to each isolate, denoted by $(V_i, T_i)$ for the $i$-th isolate.\n\n- Isolate $1$: $(V_1, T_1) = (128, 32)$. Since $128 \\ge 64$ and $32 \\ge 16$, the conditions for **VanA** are met.\n- Isolate $2$: $(V_2, T_2) = (256, 64)$. Since $256 \\ge 64$ and $64 \\ge 16$, the conditions for **VanA** are met.\n- Isolate $3$: $(V_3, T_3) = (64, 16)$. Since $64 \\ge 64$ and $16 \\ge 16$, the conditions for **VanA** are met.\n- Isolate $4$: $(V_4, T_4) = (16, 1)$. Fails VanA criteria ($T_4 < 16$). Meets VanB criteria ($16 \\ge 16$ and $1 \\le 2$). Classified as VanB.\n- Isolate $5$: $(V_5, T_5) = (8, 2)$. Fails VanA ($V_5 < 64$) and VanB ($V_5 < 16$). Meets VanC criteria ($4 \\le 8 < 16$ and $2 \\le 2$). Classified as VanC.\n- Isolate $6$: $(V_6, T_6) = (32, 1)$. Fails VanA criteria ($T_6 < 16$). Meets VanB criteria ($32 \\ge 16$ and $1 \\le 2$). Classified as VanB.\n- Isolate $7$: $(V_7, T_7) = (4, 1)$. Fails VanA ($V_7 < 64$) and VanB ($V_7 < 16$). Meets VanC criteria ($4 \\le 4 < 16$ and $1 \\le 2$). Classified as VanC.\n- Isolate $8$: $(V_8, T_8) = (12, 2)$. Fails VanA ($V_8 < 64$) and VanB ($V_8 < 16$). Meets VanC criteria ($4 \\le 12 < 16$ and $2 \\le 2$). Classified as VanC.\n- Isolate $9$: $(V_9, T_9) = (6, 1)$. Fails VanA ($V_9 < 64$) and VanB ($V_9 < 16$). Meets VanC criteria ($4 \\le 6 < 16$ and $1 \\le 2$). Classified as VanC.\n- Isolate $10$: $(V_{10}, T_{10}) = (2, 1)$. Fails VanA ($V_{10} < 64$), VanB ($V_{10} < 16$), and VanC ($V_{10} < 4$). Classified as **Other**.\n- Isolate $11$: $(V_{11}, T_{11}) = (3, 2)$. Fails VanA ($V_{11} < 64$), VanB ($V_{11} < 16$), and VanC ($V_{11} < 4$). Classified as **Other**.\n- Isolate $12$: $(V_{12}, T_{12}) = (32, 4)$. Fails VanA ($T_{12} < 16$), VanB ($T_{12} > 2$), and VanC ($V_{12} \\not\\in [4, 16)$). Classified as **Other**.\n- Isolate $13$: $(V_{13}, T_{13}) = (64, 2)$. Fails VanA criteria ($T_{13} < 16$). Meets VanB criteria ($64 \\ge 16$ and $2 \\le 2$). Classified as VanB.\n- Isolate $14$: $(V_{14}, T_{14}) = (1, 1)$. Fails VanA ($V_{14} < 64$), VanB ($V_{14} < 16$), and VanC ($V_{14} < 4$). Classified as **Other**.\n- Isolate $15$: $(V_{15}, T_{15}) = (10, 3)$. Fails VanA ($V_{15} < 64$), VanB ($V_{15} < 16$), and VanC ($T_{15} > 2$). Classified as **Other**.\n- Isolate $16$: $(V_{16}, T_{16}) = (128, 8)$. Fails VanA ($T_{16} < 16$), VanB ($T_{16} > 2$), and VanC ($V_{16} \\not\\in [4, 16)$). Classified as **Other**.\n- Isolate $17$: $(V_{17}, T_{17}) = (512, 32)$. Since $512 \\ge 64$ and $32 \\ge 16$, the conditions for **VanA** are met.\n- Isolate $18$: $(V_{18}, T_{18}) = (8, 1)$. Fails VanA ($V_{18} < 64$) and VanB ($V_{18} < 16$). Meets VanC criteria ($4 \\le 8 < 16$ and $1 \\le 2$). Classified as VanC.\n- Isolate $19$: $(V_{19}, T_{19}) = (16, 2)$. Fails VanA criteria ($T_{19} < 16$). Meets VanB criteria ($16 \\ge 16$ and $2 \\le 2$). Classified as VanB.\n- Isolate $20$: $(V_{20}, T_{20}) = (5, 2)$. Fails VanA ($V_{20} < 64$) and VanB ($V_{20} < 16$). Meets VanC criteria ($4 \\le 5 < 16$ and $2 \\le 2$). Classified as VanC.\n\nUpon completion of the classification for all $20$ isolates, we enumerate the number of isolates belonging to the VanA category. The isolates classified as VanA are numbers $1$, $2$, $3$, and $17$. Thus, the total count of VanA isolates is $N_{\\text{VanA}} = 4$.\n\nThe total number of isolates in the cohort is given as $N_{\\text{total}} = 20$. The proportion of isolates with the VanA phenotype, denoted $P_{\\text{VanA}}$, is the ratio of $N_{\\text{VanA}}$ to $N_{\\text{total}}$.\n$$P_{\\text{VanA}} = \\frac{N_{\\text{VanA}}}{N_{\\text{total}}} = \\frac{4}{20}$$\nCalculating this value gives:\n$$P_{\\text{VanA}} = \\frac{1}{5} = 0.2$$\nThe problem specifies that the final answer must be a unitless decimal rounded to four significant figures. Therefore, the proportion $0.2$ is expressed as $0.2000$.", "answer": "$$\\boxed{0.2000}$$", "id": "4641811"}, {"introduction": "The rise of vancomycin-resistant enterococci (VRE) necessitates the search for alternative therapeutic strategies, one of which is the use of synergistic drug combinations. This exercise introduces a standard method for quantifying drug interactions, the Fractional Inhibitory Concentration Index (FICI). By calculating the FICI for a combination of two beta-lactam antibiotics, you will determine if they work synergistically against VRE, providing a quantitative basis for a promising alternative treatment. [@problem_id:4641751]", "problem": "A patient with infective endocarditis due to an Enterococcus faecalis isolate harboring the VanA-type vancomycin resistance determinant is being evaluated for beta-lactam synergy as an alternative to vancomycin. In vitro susceptibility testing yields the following Minimum Inhibitory Concentrations (MICs) determined by broth microdilution: ampicillin alone $2$ and ceftriaxone alone $1024$. A checkerboard assay is performed, and the first well along the inhibition interface (no visible growth) contains ampicillin $0.25$ combined with ceftriaxone $64$.\n\nUsing the standard definition of the fractional inhibitory concentration index (FICI) derived from MICs measured alone and in combination in a checkerboard assay, compute the FICI for the ampicillinâ€“ceftriaxone combination for this isolate, and use widely accepted interpretive thresholds to decide whether the interaction is synergistic or merely additive/indifferent. Report only the numeric FICI as your final answer. Provide your answer as an exact value (no rounding) and do not include units.", "solution": "The task is to compute the fractional inhibitory concentration index (FICI) from checkerboard assay data and then interpret it using accepted thresholds for synergy versus additivity/indifference.\n\nFoundational definitions and facts:\n- The minimum inhibitory concentration (MIC) of a drug is the lowest concentration that inhibits visible bacterial growth under standardized conditions.\n- In a checkerboard assay, combinations of two drugs are tested across a two-dimensional dilution series to identify inhibitory pairs.\n- The fractional inhibitory concentration (FIC) of a drug in a combination is defined as the ratio of its concentration in the inhibitory combination to its MIC when used alone.\n- The fractional inhibitory concentration index (FICI) is defined as the sum of the two FICs for the pair of drugs.\n- Widely used interpretive thresholds categorize interactions as synergistic when the FICI is less than or equal to $0.5$, additive/indifferent when greater than $0.5$ and up to $1$, and antagonistic when greater than $1$ (with some schemes using higher cutoffs for strong antagonism).\n\nGiven data:\n- Ampicillin MIC alone = $2$.\n- Ceftriaxone MIC alone = $1024$.\n- Inhibitory combination well: ampicillin = $0.25$, ceftriaxone = $64$.\n\nCompute individual FICs:\n- For ampicillin, the FIC is the combination concentration divided by the MIC alone:\n$$\n\\text{FIC}_{\\text{ampicillin}} = \\frac{0.25}{2} = \\frac{1}{8} = 0.125.\n$$\n- For ceftriaxone, the FIC is:\n$$\n\\text{FIC}_{\\text{ceftriaxone}} = \\frac{64}{1024} = \\frac{1}{16} = 0.0625.\n$$\n\nSum to obtain the FICI:\n$$\n\\text{FICI} = \\text{FIC}_{\\text{ampicillin}} + \\text{FIC}_{\\text{ceftriaxone}} = \\frac{1}{8} + \\frac{1}{16} = \\frac{2}{16} + \\frac{1}{16} = \\frac{3}{16}.\n$$\n\nInterpretation:\n- Since $\\frac{3}{16} = 0.1875 \\leq 0.5$, this interaction is categorized as synergistic by widely accepted thresholds used in infectious diseases pharmacodynamics and clinical microbiology.\n\nThe problem requests that only the numeric FICI be reported as the final answer, in exact form and without units. The exact value is $\\frac{3}{16}$.", "answer": "$$\\boxed{\\frac{3}{16}}$$", "id": "4641751"}]}